1. UNRAVELING GESTATIONAL TROPHOBLASTIC DISEASE: A CASE SERIES HIGHLIGHTING DIAGNOSTIC CHALLENGES AND THERAPEUTIC OUTCOMES.
- Author
-
SINGH, PARUL, CHAUHAN, MEENAKSHI BARSAUL, DAHIYA, PUSHPA, MALHOTRA, VANI, CHAUDHARY, SUSHILA, SHIVANGI, and VERMA, MENKA
- Subjects
- *
GESTATIONAL trophoblastic disease , *TREATMENT effectiveness , *CHORIONIC gonadotropins , *ARTERIOVENOUS malformation , *MEDICAL personnel , *MOLAR pregnancy - Abstract
Gestational trophoblastic disease (GTD) refers to a group of pregnancy-related tumors that are recognized as the most curable gynecologic malignancies. Diagnosing GTD can be challenging, particularly after a non-molar pregnancy, due to its various presentations, which may mimic retained products with hypervascularity or arteriovenous malformation. Human chorionic gonadotropin (HCG) serves as an excellent biomarker for monitoring disease progression, response to treatment, and post-treatment surveillance. A plateaued or rising HCG level can facilitate the early detection of progression from complete or partial hydatidiform mole to GTD. Here, we present a case series involving six patients with GTD who initially presented with elevated beta-HCG levels and abnormal bleeding. Of these six patients, five were initially diagnosed with hypervascular retained products following a first-trimester abortion and underwent surgical evacuation. However, due to persistently elevated beta-HCG levels and evidence of myometrial invasion, the diagnosis was later revised to GTD. All patients were successfully managed with chemotherapy. Methotrexate, as a first-line treatment, is effective in achieving complete remission in most non-metastatic and low-risk cases. It has minimal severe toxicity, excellent cure rates, and does not appear to affect fertility. In summary, gestational trophoblastic diseases represent a diagnostic conundrum for clinicians due to their diverse presentations and potential for mimicking other conditions. Nevertheless, when these diseases are identified and managed in a timely manner, the prognosis is highly favorable, underscoring the importance of vigilant monitoring and early intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2024